Abstract:Liang Kong, 1 Shi-meng Zhang, 2 Jia-hao Chu, 3 Xin-ze Liu, 1 Lu Zhang, 1 Si-yu He, 1 Si-min Yang, 3 Rui-jun Ju, 3 Xue-tao Li 1 1 School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian 116600, People's Republic of China; 2 Department of Neurology, Linyi People's Hospital, Linyi 276003, People's Republic of China; 3 Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Beijing 102617, People's Republic of China Correspondence: Xue-tao Li School of Pharmacy, Liaoning University of Traditional Chinese Medicine, Shengming 1 Road 77, Double D Port, Dalian 116600, People's Republic of China Tel +86411 8589 0170 Fax +86411 8589 0128 Email lixuetao1979@163.com Rui-jun Ju Department of Pharmaceutical Engineering, Beijing Institute of Petrochemical Technology, Qingyuan North Road 19, Beijing 102617, People's Republic of China Tel +8610 8129 2387 Fax +8610 8129 2124 Email juruijun@bipt.edu.cn Background: Non-small cell lung cancer (NSCLC) is one of the most lethal types of cancer with highly infiltrating. Chemotherapy is far from satisfactory, vasculogenic mimicry (VM) and angiogenesis results in invasion, migration and relapse. Purpose: The objective of this study was to construct a novel CPP (mmp) modified vinorelbine and dioscin liposomes by two new functional materials, DSPE-PEG 2000 -MAL and CPP-PVGLIG-PEG 5000 , to destroy VM channels, angiogenesis, EMT and inhibit invasion and migration. Methods and Results: The targeting liposomes could be enriched in tumor sites through passive targeting, and the positively charged CPP was exposed and enhanced active targeting via electrostatic adsorption after being hydrolyzed by MMP2 enzymes overexpressed in the tumor microenvironment. We found that CPP (mmp) modified vinorelbine and dioscin liposomes with the ideal physicochemical properties and exhibited enhanced cellular uptake. In vitro and in vivo results showed that CPP (mmp) modified vinorelbine and dioscin liposomes could inhibit migration and invasion of A549 cells, destroy VM channels formation and angiogenesis, and block the EMT process. Pharmacodynamic studies showed that the targeting liposomes had obvious accumulations in tumor sites and magnificent antitumor efficiency. Conclusion: CPP (mmp) modified vinorelbine plus dioscin liposomes could provide a new strategy for NSCLC. Keywords: vinorelbine, dioscin, non-small cell lung cancer, multi-functional liposomes, tumor microenvironment, MMP2 enzymes

A Continued Study on the Stealth Liposomal Topotecan Plus Amlodipine: in Vitro and in Vivo Characterization in Non-Resistant Solid Tumors

Effect of stealthy liposomal topotecan plus amlodipine on the multidrug-resistant leukaemia cells in vitro and xenograft in mice.

A Novel Stealth Liposomal Topotecan with Amlodipine: Apoptotic Effect is Associated with Deletion of Intracellular Ca2+ by Amlodipine Thus Leading to an Enhanced Antitumor Activity in Leukemia

Mitochondrial Targeting Topotecan-Loaded Liposomes for Treating Drug-Resistant Breast Cancer and Inhibiting Invasive Metastases of Melanoma.

Antitumor activity of new liposomal prodrug of mitomycin C in multidrug resistant solid tumor: Insights of the mechanism of action

Enhanced Antitumor Effect of Novel Dual-Targeted Paclitaxel Liposomes

Enhanced Therapeutic Effects on the Multi-Drug Resistant Human Leukemia Cells in Vitro and Xenograft in Mice Using the Stealthy Liposomal Vincristine Plus Quinacrine

Characterization of PEGylated nanoliposomes co-remotely loaded with topotecan and vincristine: relating structure and pharmacokinetics to therapeutic efficacy

The in Vitro Cytotoxicity and in Vivo Toxicity of Doxorubicin Antiresistant Stealth Liposomes

Co-delivery of doxorubicin and PSC 833 (Valspodar) by stealth nanoliposomes for efficient overcoming of multidrug resistance

Co-Encapsulation of Mitoxantrone and Β-Elemene in Solid Lipid Nanoparticles to Overcome Multidrug Resistance in Leukemia

Pharmacokinetics of intravenously administered stealth liposomal doxorubicin modulated with verapamil in rats.

A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer.

Effects of stealth liposomal daunorubicin plus tamoxifen on the breast cancer and cancer stem cells

Tumor Microenvironmental Responsive Liposomes Simultaneously Encapsulating Biological and Chemotherapeutic Drugs for Enhancing Antitumor Efficacy of NSCLC

In vitro cytotoxicity of Stealth liposomes co-encapsulating doxorubicin and verapamil on doxorubicin-resistant tumor cells.

Enhancing Solid Tumor Therapy with Sequential Delivery of Dexamethasone and Docetaxel Engineered in a Single Carrier to Overcome Stromal Resistance to Drug Delivery.

Drug Resistance Reversal Activity of Anticancer Drug Loaded Solid Lipid Nanoparticles in Multi-Drug Resistant Cancer Cells

Targeting Therapy with Mitosomal Daunorubicin Plus Amlodipine Has the Potential to Circumvent Intrinsic Resistant Breast Cancer

Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.

PTD Modified Paclitaxel Anti-Resistant Liposomes for Treatment of Drug-Resistant Non-Small Cell Lung Cancer